On Monday, U.S. President Donald Trump signed a significant executive order aimed at addressing the rising cost of pharmaceuticals in the country. This sweeping directive mandates that pharmaceutical manufacturers reduce the prices of their drugs to align more closely with international price standards. For years, the high cost of prescription medications has been a contentious issue in the United States, with many Americans and healthcare providers calling for reform. The new executive order attempts to tackle this by setting price targets that drug makers must meet within the next 30 days, with the possibility of further price reductions if these targets are not achieved.